UPI: ‘Zombie’ cells in brain could serve as treatment target in Alzheimer’s, study says
December 13, 2021
Dr. Habil Zare, Glenn Biggs Institute, Cell Systems and Anatomy, is quoted in this article. Read story
December 13, 2021
Dr. Habil Zare, Glenn Biggs Institute, Cell Systems and Anatomy, is quoted in this article. Read story
December 10, 2021
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO, Texas, and WINSTON-SALEM, N.C. (Dec. 10, 2021) – Emerging evidence suggests it may be possible to treat Alzheimer’s disease by targeting therapy at senescent cells in the brain. Today (Dec. 10) in the journal Nature Aging, a team from The University of Texas Health Science Center at San […]
October 14, 2021
Dr. Sudha Seshadri, Neurology, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was a guest on Texas Public Radio’s “The Source” and discussed how UT Health San Antonio and The University of Texas Rio Grande Valley will work together to address the disproportionate impact of Alzheimer’s in Latinos at a new nationally designated Alzheimer’s Disease […]
October 5, 2021
San Antonio earned the national designation of “Dementia Friendly City” by having a community grassroots effort working to welcome and support those with the condition, and provide helpful resources to caregivers. The Oct. 4 presentation took place at the UT Health San Antonio School of Nursing, whose Caring for the Caregiver program collaborates with the […]
October 5, 2021
San Antonio was the third Texas city to earn the designation “Dementia Friendly City” by having a community grassroots effort working to welcome and support those with the condition, and provide helpful resources to caregivers. The designation is from the national nonprofit support organization Dementia Friendly America.
September 27, 2021
An interview with Dr. Sudha Seshadri, Neurology, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, is included in this story. Dr. Seshadri discussed the dementia-like issues found in COVID-19 patients. Watch interview